Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?

Immunotherapy (IO) has altered the therapeutic landscape for multiple cancers. There are emerging data from retrospective studies on a subset of patients who do not benefit from IO, instead experiencing rapid progression with dramatic acceleration of disease trajectory, termed ‘hyperprogressive dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Adashek, Jacob J., Subbiah, Ishwaria M., Matos, Ignacio, Garralda, Elena, Menta, Arjun K., Ganeshan, Dhakshina Moorthy, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726601/
https://www.ncbi.nlm.nih.gov/pubmed/32101722
http://dx.doi.org/10.1016/j.trecan.2020.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726601/
https://www.ncbi.nlm.nih.gov/pubmed/32101722
http://dx.doi.org/10.1016/j.trecan.2020.01.005

Ejemplares similares